Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

QuidelOrtho Affirms FY2025 Adj EPS Guidance of $2.07-$2.57 vs $3.25 Est; Affirms FY2025 Sales Guidance of $2.60B-$2.81B vs $2.81B Est

Author: Benzinga Newsdesk | May 07, 2025 03:07pm
QuidelOrtho (NASDAQ:QDEL) affirms FY2025 Adj EPS guidance from $2.07-$2.57 to $2.07-$2.57 vs $3.25 analyst estimate. Affirms FY2025 sales outlook from $2.60 billion-$2.81 billion to $2.60 billion-$2.81 billion vs $2.81 billion estimate.

Posted In: QDEL


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist